The goal of the Hepatobiliary, Pancreas and Gastrointestinal Surgical Oncology program is to provide the highest quality, state of the art, and effective treatments for patients with benign and malignant diseases of all areas of the digestive tract and abdomen including the liver (primary and metastatic), pancreas (including cystic neoplasms and neuroendocrine tumors), bile duct, gallbladder, stomach, duodenum and small intestine (including carcinoid tumors), peritoneum, retroperitoneum (including sarcomas), colon, rectum, and anus.
Our experience and success is attributed to our multidisciplinary team of surgical oncologists, medical, radiation and interventional oncologists, radiologists, pathologists and advanced care practitioners. We provide surgical expertise in minimally invasive techniques including laparoscopic and robotic resections as well as hyperthermic infusional chemotherapy and our leadership in multidisciplinary tumor board assures patients the highest standard of multimodality therapy for their disease.
- Kamran Idrees, M.D.
- Christina Bailey, M.D., M.S.C.I.
- Deepa Magge, MD
- Sekhar Padmanabhan, MD
- Marcus C.B. Tan, MBBS, FACS